Outcomes of non-acute coronary syndrome patients discharged from the emergency department with troponin positivity

Canadian Journal of Emergency Medicine

Volumn 16, Issue 1, 2014, Pages 41-52

  Brunner, Nathan W ^a   Scheuermeyer, Frank X ^a   Grafstein, Eric ^a   Ramanathan, Krishnan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Discharge; Mortality; Outcomes; Troponin

Indexed keywords

TROPONIN;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PHYSICIAN; RETROSPECTIVE STUDY; RISK; BLOOD; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; PROGNOSIS; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; THORAX PAIN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHEST PAIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PATIENT READMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TROPONIN;

EID: 84892750365     PISSN: 14818035     EISSN: None     Source Type: Journal    
DOI: 10.2310/8000.2013.130949     Document Type: Article

References (40)

1. Setiadi BM, Lei H, Chang J. Troponin not just a simple cardiac marker: prognostic significance of cardiac troponin. Chin Med J 2009;122:351-8.
2. Ottani F, Galvani M, Nicolini FA, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000; 140:917-27, doi:10.1067/mhj.2000.111107.
3. Setsuta K, Seino Y, Kitahara Y, et al. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure. Circ J 2008;72:569-74, doi:10.1253/circj.72. 569.
4. Demir M, Kanadasi M, Akpinar O, et al. Cardiac troponin T as a prognostic marker in patients with heart failure: a 3-year outcome study. Angiology 2007;58:603-9, doi:10.1177/ 0003319707307344.
5. Chow GV, Hirsch GA, Spragg DD, et al. Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia. Medicine 2010; 89:141-8, doi:10.1097/MD.0b013e3181dddb3b.
6. Becattini C, Vedovati MC, Agnellli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2010;116:427-33, doi:10.1161/CIRCULATIONAHA. 106.680421.
7. Stein PD, Matta F, Janjua M, et al. Outcome in stable patients with acute pulmonary embolism who had right ventricular enlargement and/or elevated levels of troponin I. Am J Cardiol 2010;106:558-63, doi:10.1016/j.amjcard.2010.03.071.
8. Martins CS, Rodrigues MJO, Miranda VP, et al. Prognostic value of cardiac troponin I in patients with COPD acute exacerbation. Neth J Med 2009;67:341-9.
9. Choy JB, Armstrong PW, Ulan RA, et al. Do cardiac troponins provide prognostic insight in hemodialysis patients? Can J Cardiol 2003;19:907-11.
10. McGill D, Talaulikar G, Potter JM, et al. Over time, highsensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010;411:936-9, doi:10.1016/j.cca.2010.03.004.
11. Kalla C, Raveh D, Algur N, et al. Incidence and significance of a positive troponin test in bacteremic patients without acute coronary syndrome Am J Med 2008;121:909-15, doi:10.1016/j.amjmed.2008.05.037.
12. Garrett MC, Komotar RJ, Starke RM, et al. Elevated troponin levels are predictive of mortality in surgical intracerebral hemorrhage patients. Neurocrit Care 2010;12: 199-203, doi:10.1007/s12028-009-9245-5.
13. Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiac morbidity and outcome after subarachnoid hemorrhage. Circulation 2005;112:2851-6, doi:10.1161/ CIRCULATIONAHA.105.533620.
14. Milani RV, Fitzgerald R, Milani JN, et al. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheter Cardiovasc Interv 2009;74:819-22, doi:10.1002/ ccd.22160.
15. Croal BL, Hillis GS, Gibson PH, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:1468-75, doi:10. 1161/CIRCULATIONAHA.105.602370.
16. Oshima K, Kunimoto F, Takahashi T, et al. Postoperative cardiac troponin I (cTnI) level and its prognostic value for patients undergoing mitral valve surgery. Int Heart J 2010; 51:166-9, doi:10.1536/ihj.51.166.
17. Pham MX, Whooley MA, Evans GT Jr, et al. Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am Heart J 2004;148:776-82, doi:10.1016/j.ahj.2004.03.058.
18. Carlson ER, Percy RF, Angiolillo DJ, et al. Prognostic significance of troponin T elevation in patients without chest pain. Am J Cardiol 2008;102:668-71, doi:10.1016/j.amjcard. 2008.04.046.
19. Srivathsan K, Showalter J, Wilkens J, et al. Cardiovascular outcome in hospitalized patients with minimal troponin elevation and normal creatine phosphokinase. Int J Cardiol 2004;97:221-4, doi:10.1016/j.ijcard.2003.08.018.
20. Alaiti MA, Maroo A, Edel TB. Troponin levels after cardiac electrophysiology procedures: review of the literature. Pacing Clin Electrophysiol 2009;32:800-10, doi:10.1111/j.1540-8159. 2009.02370.x.
21. Loeb HS, Liu JC. Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention. Clin Cardiol 2010;33:E40-4, doi:10.1002/clc.20425.
22. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116: 2634-53, doi:10.1161/CIRCULATIONAHA.107.187397.
23. Beveridge R. CAEP issues. The Canadian Triage and Acuity Scale: a new and critical element in health care reform. Canadian Association of Emergency Physicians. J Emerg Med 1998;16:507-11, doi:10.1016/S0736-4679(98) 00031-6.
24. Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med 1996;27:305-8, doi:10.1016/ S0196-0644(96)70264-0.
25. Agarwal R, Light RP. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:528-36, doi:10.2215/CJN.07770910.
26. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81, doi:10.1016/S0140-6736(10)60674-5.
27. Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J 2005;150:161-7, doi:10.1016/j.ahj.2004.08.041.
28. Roderick PJ, Atkins RJ, Smeeth L, et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009;53:950-60, doi:10.1053/j.ajkd.2008.12.036.
29. Dong SL, Bullard MJ, Meurer DP, et al. Predictive validity of a computerized emergency triage tool. Acad Emerg Med 2007;14:16-21, doi:10.1111/j.1553-2712.2007. tb00362.x.
30. Phillips RS, Wenger NS, Teno J, et al. Choices of seriously ill patients about cardiopulmonary resuscitation: correlates and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med 1996;100:128-37, doi:10.1016/ S0002-9343(97)89450-8.
31. Lim W, Cook DJ, Griffith LE, et al. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care 2006;15:280-8
32. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-6, doi:10. 1001/jama.2011.338.
33. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77, doi:10.1056/NEJMoa0903515.
34. de Lemos JA, Drazner MH, Omland T, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12, doi:10.1001/jama. 2010.1768.
35. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-204, doi:10.1093/eurheartj/ ehq251.
36. Fundaro C, Guzzetti S. Prognostic value of stable troponin T elevation in patients discharged from emergency department. J Cardiovasc Med (Hagerstown) 2010;11:276-80, doi:10.2459/JCM.0b013e328336ecc5
37. Venge P, Lagerqvist B, Diderholm E, et al. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002;89:1035-41, doi:10.1016/S0002-9149(02) 02271-3.
38. Heeschen C, Deu A, Langenbrink L, et al. Analytical and diagnostic performance of troponin assays in patients suspicious for acute coronary syndromes. Clin Biochem 2000; 33:359-68, doi:10.1016/S0009-9120(00)00144-2.
39. Apple FS, Smith SW, Pearce LA, et al. Use of the Centaur TnI Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54: 723-8, doi:10.1373/clinchem.2007.097162.
40. Panteghini M, Pagani Y, Yeo KT, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32, doi:10.1373/clinchem.2003.026815.